Ventricular Fibrillation
2
Pipeline Programs
4
Companies
7
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
BiotronikGermany - Berlin
4 programs2
ICD or CRT-D with Home Monitoring feature deactivatedPhase 41 trial
Implantable Cardioverter DefibrillatorPhase 41 trial
Home Monitoring provided by Biotronik ICD and CRT-D devicesN/A1 trial
SD01 ICD leadN/A1 trial
Active Trials
+1 more trials
Rhythm PharmaceuticalsBOSTON, MA
1 programLeft Ventricular Capture Management StudyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
BiotronikICD or CRT-D with Home Monitoring feature deactivated
BiotronikImplantable Cardioverter Defibrillator
PEEL TherapeuticsVector change defibrillation
BiotronikSD01 ICD lead
BiotronikHome Monitoring provided by Biotronik ICD and CRT-D devices
Rhythm PharmaceuticalsLeft Ventricular Capture Management Study
Clinical Trials (7)
Total enrollment: 1,745 patients across 7 trials
Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function
Start: Jul 2007Est. completion: Aug 2013720 patients
Phase 4Completed
Remote Follow-up of Patients Receiving Implantable Cardioverter Defibrillator for Prophylactic Therapy
Start: Jan 2004Est. completion: Jul 2008155 patients
Phase 4Completed
Investigation of Cognitive Function Before and After Induced Ventricular Fibrillation in Electrophysiological (EP) Study
30 patients
N/AUnknown
DOuble SEquential External Defibrillation for Refractory VF Pilot Study
Start: Mar 2018Est. completion: Mar 2020
N/ACompleted
SD01 Registry (SD01 ICD Lead)
Start: Mar 2014Est. completion: Sep 2024280 patients
N/ACompleted
European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco)
Start: Oct 2008Est. completion: Oct 2016409 patients
N/ATerminated
Left Ventricular Capture Management Study
Start: Oct 2007Est. completion: Dec 2010151 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space